Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
SK pharmteco is a global CDMO, with locations in the US, EU, and South Korea. The company’s core capabilities center on small ...
As gene and cell therapies evolve toward increasingly complex genetic designs, the ability to manufacture high-quality viral vectors at scale is becoming a critical bottleneck in development.A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results